Yeast postbiotic effectively improves flu symptoms
Efficacy of a yeast postbiotic on cold/flu symptoms in healthy children: A randomized-controlled trial.
We evaluated the impact of EpiCor, a yeast-derived postbiotic, on flu and cold symptoms in children aged 4-12. Over the course of 84 days, 256 children either received EpiCor or a placebo during the flu season.
Our findings showed that those taking EpiCor experienced significantly less severity in cold and flu symptoms compared to the placebo group. This included fewer sore throats and muscle aches, along with reduced reliance on cold and flu medications.
Overall, EpiCor appears to be a safe option to help boost immune function in children during cold and flu season.
Read More
Vitamin D enhances influenza defenses
Vitamin D promotes epithelial tissue repair and host defense responses against influenza H1N1 virus and Staphylococcus aureus infections.
We recently examined how vitamin D impacts our body's response to influenza H1N1, an important viral infection. Utilizing 142 clinical cases from the Department of Otolaryngology at Sun Yat-sen University, we dug into the effects of vitamin D deficiency on chronic rhinosinusitis (CRS), a condition that frequently involves damage to the airway's lining. By studying airway organoids treated with vitamin D, we were able to simulate how this treatment might bolster our defenses against flu viruses and bacteria like Staphylococcus aureus.
Our observations showed that many patients with CRS suffered from vitamin D deficiency. Notably, those who received vitamin D treatment exhibited faster cell growth in the nasal epithelium. When exposed to the H1N1 virus, these treated organoids demonstrated a remarkable ability to fend off the infection better than those without vitamin D. This protection stemmed from enhancements in host defenses, including improved production of antimicrobial proteins, reduced inflammation, and better epithelial integrity—crucial factors in fighting off infections.
We also uncovered some fascinating insights about the biological mechanisms at work. Vitamin D seemed to actively influence how epithelial cells develop and repair themselves while managing immune responses against infections. These findings underscore the significance of addressing vitamin D deficiency, especially for those vulnerable to respiratory illnesses.
Read More
Probiotic shows potential, inconclusive for flu
Probiotic Bifidobacterium lactis Probio-M8 treated and prevented acute RTI, reduced antibiotic use and hospital stay in hospitalized young children: a randomized, double-blind, placebo-controlled study.
We examined how the probiotic Bifidobacterium lactis Probio-M8 impacts acute respiratory tract infections in young hospitalized children. This double-blind, placebo-controlled study involved 120 children divided into two groups: one receiving probiotics and the other a placebo.
Our findings suggest that the probiotic could help manage respiratory infections safely, potentially reducing antibiotic use and shortening hospital stays. However, the overall effectiveness in preventing flu is still inconclusive, and more research is necessary to solidify these benefits.
Read More
Probiotics improve flu immunity
Lactobacillus paracasei feeding improves immune control of influenza infection in mice.
We explored how the probiotic Lactobacillus paracasei can enhance the immune response to influenza in a mouse model. The study showed that feeding mice this probiotic led to a stronger defense against the flu, with quicker viral clearance and fewer inflammatory cells in the lungs.
While this research highlights promising benefits of probiotics like L. paracasei, it was done in mice, meaning we need more studies to understand their effects in children. Overall, these findings suggest that certain probiotics may help improve immune control of respiratory infections.
Read More
Vitamin D may reduce flu risk
The effectiveness of interventions to reduce the transmission of acute respiratory infections in care homes: a systematic review.
We explored how vitamin D supplementation might help reduce the risk of respiratory infections, particularly the flu, in care homes. Our systematic review of several randomized controlled trials focused on interventions to reduce the transmission of acute respiratory infections, looking beyond just vaccines.
Our findings highlighted that high-dose vitamin D supplementation led to a significant decrease in the incidence of acute respiratory infections, reducing the likelihood of getting sick. Specifically, one trial indicated a 40% reduction in these infections among participants receiving vitamin D compared to those who did not.
However, not all studies we reviewed showed compelling results for related supplements like vitamins, minerals, probiotics, and herbal aids, which did not significantly impact infection rates. This means that while vitamin D supplementation shows promise, more research is needed to fully understand its effects and confirm its benefits in combating flu and other respiratory illnesses.
Read More